MFN model for Medicaid revealed by CMS

The Trump administration has released details of a most-favoured nation (MFN) drug pricing programme for medicines provided by Medicaid, the federal health insurance programme for people with low incomes and the disabled.

The Centers for Medicare & Medicaid Services (CMS) is calling its pilot scheme the GENErating cost Reductions fOr US Medicaid or GENEROUS model, and is now seeking companies that wish to take part.

The premise is similar to the MFN system Trump is trying to implement for Medicare – with deals already announced with Pfizer, AstraZeneca, and Merck KGaA – and will tie…